Development and translation of a novel radioligand to measure pathological changes in glucocorticoid receptor expression in the brain
Development and translation of a novel radioligand to measure pathological changes in glucocorticoid receptor expression in the brain
批准号:
9427881
负责人:
Michael John Evans
金额:
$69.08万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-12-01 至 2020-11-30
关键词:
AddressAdoptedAdrenal Cortex HormonesAdrenalectomyAffinityAndrogen ReceptorAnimal ModelAnimalsAntidepressive AgentsAntineoplastic AgentsApplications GrantsBackBasic ScienceBindingBiodistributionBiologicalBrainBreastCarbonChemicalsChemistryClinicalClinical ResearchCommunitiesDataDevelopmentDrug TargetingEndocrinologyEstrogen ReceptorsFamilyFemaleFluorineGenerationsGlucocorticoid ReceptorGoalsGrantHippocampus (Brain)HormonesHumanImageImaging DeviceIn VitroInjectionsInvestigational TherapiesLeadLibrariesLigandsMajor Depressive DisorderMalignant NeoplasmsMeasuresMental DepressionMood DisordersMusNeurosciencesNormal tissue morphologyNuclear Hormone ReceptorsOvarianPathologicPermeabilityPharmaceutical PreparationsPharmacologyPhenolsPhenotypePositron-Emission TomographyPreparationProstatePublic HealthRadiochemistryRattusReceptor SignalingReportingResearch Project GrantsRodentRoleScanningSerum ProteinsSignal TransductionStructureSystems AnalysisTherapeuticTissuesToxic effectToxicologyTranslatingTranslationsanimal databaseclinically relevantdosimetrydrug developmentfirst-in-humanhealthy volunteerhuman studyin vivoinnovationmalemannanomolarneuroimagingnovelnovel therapeuticspharmacokinetic characteristicpre-clinicalradioligandradiotracerreceptorreceptor expressionrestorationserial imagingtargeted treatmentuptake
中文摘要
项目摘要
本课题的目的是研制一种靶向糖皮质激素受体(GR)的脑渗透性放射性配体。
在具体目标1中,对GR具有亚纳摩尔亲和力的非甾体配体将被放射性氟化,并且其
将在体外评估药理学。将在小鼠体内测定GR的特异性结合,
具体目标2.还将计算eIND申请的大鼠剂量测定估计值和毒性。在特定
第三,将进行首次人体研究,以确定人体剂量。该项目的数据将
赋予社区一个新的翻译成像工具,研究GR表达变化的作用,
严重的情绪障碍比如抑郁症
英文摘要
Project Abstract
The goal of this project is to develop a brain permeable radioligand targeting the glucocorticoid receptor (GR).
A non-steroidal ligand with sub-nanomolar affinity for GR will be radiofluorinated in specific aim 1, and its
pharmacology will be assessed in vitro. Specific binding for GR will be determined in vivo in mice during
specific aim 2. Rat dosimetry estimates and toxicity will also be calculated for an eIND application. In specific
aim 3, a first in man study will be conducted to determine human dosimetry. The data from this project will
confer upon the community a new translational imaging tool to study the role of GR expression changes in
severe mood disorders like depression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
-
批准号:10294866
-
项目类别:
-
资助金额:$67.51万
-
财政年份:2021
-
负责人:Michael John Evans
-
依托单位:
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
-
批准号:10441572
-
项目类别:
-
资助金额:$64.34万
-
财政年份:2021
-
负责人:Michael John Evans
-
依托单位:
Developing a pretargeting strategy to detect Fe(II) for nuclear medicine applications
-
批准号:10608162
-
项目类别:
-
资助金额:$64.21万
-
财政年份:2021
-
负责人:Michael John Evans
-
依托单位:
Development of a translational imaging tool as a predictive biomarker for anti-PD-1/PD-L1 immunotherapies
-
批准号:9904618
-
项目类别:
-
资助金额:$59.13万
-
财政年份:2018
-
负责人:Michael John Evans
-
依托单位:
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin
-
批准号:8990827
-
项目类别:
-
资助金额:$24.11万
-
财政年份:2014
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:8842513
-
项目类别:
-
资助金额:$5.2万
-
财政年份:2014
-
负责人:Michael John Evans
-
依托单位:
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin
-
批准号:8786620
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2014
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:8641685
-
项目类别:
-
资助金额:$54.14万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:9247931
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:9040777
-
项目类别:
-
资助金额:$63.13万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:9379051
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
Noninvasive measurement of oncogenic signaling pathways with 89Zr-transferrin
-
批准号:8425727
-
项目类别:
-
资助金额:$9.08万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
Annotating Oncogene Status in Prostate Cancer with Zr-89-transferrin PET
-
批准号:8499915
-
项目类别:
-
资助金额:$54.88万
-
财政年份:2013
-
负责人:Michael John Evans
-
依托单位:
海外基金